JP2008517605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517605A5 JP2008517605A5 JP2007538172A JP2007538172A JP2008517605A5 JP 2008517605 A5 JP2008517605 A5 JP 2008517605A5 JP 2007538172 A JP2007538172 A JP 2007538172A JP 2007538172 A JP2007538172 A JP 2007538172A JP 2008517605 A5 JP2008517605 A5 JP 2008517605A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- cell
- polynucleotide
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims 16
- 210000004027 cell Anatomy 0.000 claims 7
- 102000040430 polynucleotide Human genes 0.000 claims 6
- 108091033319 polynucleotide Proteins 0.000 claims 6
- 239000002157 polynucleotide Substances 0.000 claims 6
- 102000004378 Melanocortin Receptors Human genes 0.000 claims 5
- 108090000950 Melanocortin Receptors Proteins 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 102000008316 Type 4 Melanocortin Receptor Human genes 0.000 claims 1
- 108010021436 Type 4 Melanocortin Receptor Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000004071 biological effect Effects 0.000 claims 1
- 210000004899 c-terminal region Anatomy 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62196004P | 2004-10-25 | 2004-10-25 | |
| PCT/US2005/038431 WO2006047535A2 (en) | 2004-10-25 | 2005-10-25 | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008517605A JP2008517605A (ja) | 2008-05-29 |
| JP2008517605A5 true JP2008517605A5 (enExample) | 2008-11-20 |
Family
ID=36228385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007538172A Pending JP2008517605A (ja) | 2004-10-25 | 2005-10-25 | メラノコルチン受容体結合性ミメティボディ、組成物、方法および用途 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20060105951A1 (enExample) |
| EP (1) | EP1812046B1 (enExample) |
| JP (1) | JP2008517605A (enExample) |
| KR (1) | KR101255140B1 (enExample) |
| CN (1) | CN101437540B (enExample) |
| AT (1) | ATE501731T1 (enExample) |
| AU (1) | AU2005299440B2 (enExample) |
| BR (1) | BRPI0518411A2 (enExample) |
| CA (1) | CA2585287A1 (enExample) |
| CY (1) | CY1111486T1 (enExample) |
| DE (1) | DE602005026970D1 (enExample) |
| DK (1) | DK1812046T3 (enExample) |
| EA (1) | EA200700944A1 (enExample) |
| EC (1) | ECSP077416A (enExample) |
| ES (1) | ES2363023T3 (enExample) |
| HR (1) | HRP20110405T1 (enExample) |
| IL (1) | IL182683A0 (enExample) |
| MA (1) | MA28943B1 (enExample) |
| ME (1) | ME01234B (enExample) |
| MX (1) | MX2007004974A (enExample) |
| NO (1) | NO20072499L (enExample) |
| PL (1) | PL1812046T3 (enExample) |
| PT (1) | PT1812046E (enExample) |
| RS (1) | RS51789B (enExample) |
| SI (1) | SI1812046T1 (enExample) |
| TN (1) | TNSN07157A1 (enExample) |
| WO (1) | WO2006047535A2 (enExample) |
| ZA (1) | ZA200704260B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910101B2 (en) * | 2004-10-25 | 2011-03-22 | Centocor, Inc. | Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| US7790671B2 (en) * | 2005-10-07 | 2010-09-07 | Codman & Shurtleff, Inc. | Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| AU2009257631B2 (en) | 2008-06-09 | 2014-07-24 | Palatin Technologies, Inc. | Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| AR072072A1 (es) * | 2008-06-09 | 2010-08-04 | Palatin Technologies Inc | Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669 |
| US8614185B2 (en) * | 2009-05-04 | 2013-12-24 | Centocor Ortho Biotech Inc. | Fusion proteins of alpha-MSH derivatives and Fc |
| WO2010144341A2 (en) | 2009-06-08 | 2010-12-16 | Palatin Technologies, Inc. | Lactam-bridged melanocortin receptor-specific peptides |
| UY32690A (es) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| CN105037502A (zh) | 2009-06-08 | 2015-11-11 | 帕拉丁科技公司 | 黑皮质素受体特异性肽 |
| WO2011063366A1 (en) | 2009-11-23 | 2011-05-26 | Palatin Technologies, Inc. | Melanocortin-1 receptor-specific cyclic peptides |
| KR20120102716A (ko) | 2009-11-23 | 2012-09-18 | 팔라틴 테크놀로지스 인코포레이티드 | 멜라노코르틴-1 수용체 특이적 선형 펩티드 |
| JP2020141710A (ja) * | 2011-07-06 | 2020-09-10 | ゲンマブ エー／エス | 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節 |
| CN113272330B (zh) * | 2019-03-02 | 2024-07-26 | 南通壹宸生物医药科技有限公司 | 一种双特异抗体 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000033658A1 (en) | 1998-12-09 | 2000-06-15 | Eleanor Roosevelt Institute | Composition and method for regulation of body weight and associated conditions |
| AU2001275930B2 (en) * | 2000-07-14 | 2007-05-10 | Eisai Inc. | Alpha-msh related compounds and methods of use |
| AU2003256336A1 (en) * | 2002-06-28 | 2004-01-19 | Centocor, Inc. | Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| EP1545608A4 (en) * | 2002-06-28 | 2006-09-13 | Centocor Inc | CH1-DELETED MAMMED MUICETIC BODIES, COMPOSITIONS, METHODS AND APPLICATIONS |
| EA011583B1 (ru) * | 2004-03-31 | 2009-04-28 | Сентокор, Инк. | Миметические антитела glp-1 человека, композиции, способы и применения |
-
2005
- 2005-10-25 US US11/257,851 patent/US20060105951A1/en not_active Abandoned
- 2005-10-25 BR BRPI0518411-8A patent/BRPI0518411A2/pt not_active IP Right Cessation
- 2005-10-25 PT PT05819741T patent/PT1812046E/pt unknown
- 2005-10-25 CA CA002585287A patent/CA2585287A1/en not_active Abandoned
- 2005-10-25 ES ES05819741T patent/ES2363023T3/es not_active Expired - Lifetime
- 2005-10-25 DE DE602005026970T patent/DE602005026970D1/de not_active Expired - Lifetime
- 2005-10-25 JP JP2007538172A patent/JP2008517605A/ja active Pending
- 2005-10-25 ME MEP-2011-85A patent/ME01234B/me unknown
- 2005-10-25 WO PCT/US2005/038431 patent/WO2006047535A2/en not_active Ceased
- 2005-10-25 AU AU2005299440A patent/AU2005299440B2/en not_active Ceased
- 2005-10-25 CN CN2005800447902A patent/CN101437540B/zh not_active Expired - Fee Related
- 2005-10-25 EA EA200700944A patent/EA200700944A1/ru unknown
- 2005-10-25 EP EP05819741A patent/EP1812046B1/en not_active Expired - Lifetime
- 2005-10-25 DK DK05819741.9T patent/DK1812046T3/da active
- 2005-10-25 SI SI200531295T patent/SI1812046T1/sl unknown
- 2005-10-25 MX MX2007004974A patent/MX2007004974A/es unknown
- 2005-10-25 AT AT05819741T patent/ATE501731T1/de active
- 2005-10-25 KR KR1020077011487A patent/KR101255140B1/ko not_active Expired - Fee Related
- 2005-10-25 RS RS20110230A patent/RS51789B/sr unknown
- 2005-10-25 HR HR20110405T patent/HRP20110405T1/hr unknown
- 2005-10-25 PL PL05819741T patent/PL1812046T3/pl unknown
-
2007
- 2007-04-19 IL IL182683A patent/IL182683A0/en unknown
- 2007-04-23 MA MA29843A patent/MA28943B1/fr unknown
- 2007-04-24 TN TNP2007000157A patent/TNSN07157A1/fr unknown
- 2007-04-25 EC EC2007007416A patent/ECSP077416A/es unknown
- 2007-05-15 NO NO20072499A patent/NO20072499L/no not_active Application Discontinuation
- 2007-05-24 ZA ZA200704260A patent/ZA200704260B/xx unknown
-
2011
- 2011-05-23 CY CY20111100502T patent/CY1111486T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4309741A1 (en) | Cyclic compound having inhibitory effect selective for kras but not for hras and nras | |
| JP7659015B2 (ja) | 免疫調節剤としての１，２，４－オキサジアゾールおよびチアジアゾール化合物 | |
| JP2008517605A5 (enExample) | ||
| EP4512818A1 (en) | Cyclic compound having selective kras inhibitory effect on hras and nras | |
| JP2008504850A5 (enExample) | ||
| JPWO2020111238A1 (ja) | ペプチド化合物、またはアミド化合物の脱保護法および固相反応における脱樹脂方法、並びにペプチド化合物の製造方法 | |
| WO2007002261A3 (en) | IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF | |
| JP2007532098A5 (enExample) | ||
| WO2006036834A3 (en) | MODIFIED Fc MOLECULES | |
| RU2011125367A (ru) | Конъюгаты лептина и аналогов лептина и их применение | |
| JP2007530435A5 (enExample) | ||
| EP2368907A3 (en) | Anti-Abeta antibodies and their use | |
| RU2010151725A (ru) | Аминокислотные последовательности, направленные против cхcr4 и других gpcr, и соединения, включаюшие их | |
| SG158149A1 (en) | Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides | |
| WO2003076592A3 (en) | Novel method for delivery and intracellular synthesis of sirna molecules | |
| WO2003020932A1 (en) | Novel secretory proteins and dna thereof | |
| EP4592308A1 (en) | Cyclic compound having selective kras inhibitory effect on hras and nras | |
| WO2006087550A8 (en) | Amyloid-binding peptides, analogues and uses thereof | |
| CN118354781A (zh) | 白介素-23受体的肽抑制剂 | |
| JP2004500125A (ja) | アンギオペプチンによって確認される機能性受容体としてのＧＰＣＲｘ１１を発現し、アゴニストおよびアンタゴニストのスクリーニングに役立つ組換え細胞系 | |
| HRP20110405T1 (hr) | Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe | |
| JP2005527479A5 (enExample) | ||
| JPWO2008038599A1 (ja) | 軸索再生促進剤 | |
| JP2008517616A5 (enExample) | ||
| JP2005507245A5 (enExample) |